Chemoprevention of Colorectal Cancer by Mesalamine/Sulfasalazine
A method for preventing or treating colorectal cancer in a patient possessing human tropomyocin isoform TC22 is presented. Also presented is a method for evaluating TC22 expression reduction activity of a compound.
Attached files:Patents:US 20,110,059,924
Inventor(s):
DAS KIRON M [US]; LIN JIM CHUNG-CHIN [US]
Type of Offer:
Licensing
« More Biotech Patents